We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Novel fusion protein confers ATRA resistance in atypical acute promyelocytic leukemia, suggesting a new target for therapy.
No takes yet. Share an insight, caveat, or question.
Dong et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: